Company / Free Cash Flow per Share
Amphstar Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$2.55
FY2025
5-year range
$1.37 / $3.59
FY2021-FY2025
Trend
-29.0%
vs FY2024
Sector context
#32 of 192
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s free cash flow per share of $2.55 is higher than 83% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.18 in FY2018 to $3.59 in FY2024.
Based on SEC 10-K filings.
2.55 in FY2025 with a 5-year CAGR of +38.3%. Top quartile in the Health Care sector.
Declined from $3.02 to $2.55 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +23.1%
- 5-Year CAGR
- +38.3%
- 10-Year CAGR
- -
Sector benchmark
+112.8% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 29.0% year-over-year.
- Ranks #32 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.55 | -29.0% |
| FY2024 | $3.59 | +18.7% |
| FY2023 | $3.02 | +121.2% |
| FY2022 | $1.37 | -8.1% |
| FY2021 | $1.49 | +195.5% |
| FY2020 | $0.50 | +11222.8% |
| FY2019 | $0.00 | +102.4% |
| FY2018 | -$0.18 | -308.0% |
| FY2017 | $0.09 | -76.6% |
| FY2016 | $0.38 | +419.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026